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Purpose: Prostate tumor volume calculated after surgery using pathologic tissue has been shown to be an independent risk factor 
for biochemical recurrence. Nonetheless, prostate size varies among individuals, regardless of the presence or absence of cancer. 
We assumed to be lower margin positive rate in the surgical operation, when the prostate volume is larger and the tumor lesion 
is same. Thus, we defined the tumor-prostate ratio in the ratio of tumor volume to prostate volume. In order to compensate the 
prostate tumor volume, the effect of tumor-prostate ratio on biochemical recurrence was examined.
Materials and Methods: This study included 251 patients who underwent open retropubic radical prostatectomy for prostate 
cancer in a single hospital. We analyzed the effects of tumor volume and tumor-prostate ratio, as well as the effects of known risk 
factors for biochemical recurrence, on the duration of disease-free survival.
Results: In the univariate analysis, the risk factors that significantly impacted disease-free survival time were found to be a 
prostate-specific antigen level ≥10 ng/mL, a tumor volume ≥5 mL, tumor-prostate ratio ≥10%, tumor capsular invasion, 
lymph node invasion, positive surgical margins, and seminal vesicle invasion. In the multivariate analysis performed to evaluate 
the risk factors found to be significant in the univariate analysis, positive surgical margins (hazard ratio=3.066) and a tumor 
density ≥10% (hazard ratio=1.991) were shown to be significant risk factors for biochemical recurrence.
Conclusions: Tumor-prostate ratio, rather than tumor volume, should be regarded as a significant risk factor for biochemical 
recurrence.
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INTRODUCTION
Numerous studies have been conducted to determine 
factors effecting the prognosis of patients after radical 
prostatectomy, especially regarding the recurrence of lo-
calized prostate cancer. Prostate-specific antigen (PSA) 
levels, the Gleason score after radical prostatectomy, the 
postoperative pathological tumor grade, and positive sur-
gical margins are important independent prognostic fac-
tors that have been used to predict whether prostate can-
cer has been completely cured in a given patient [1].
Prostate tumor volume is associated with cancer cell dif-
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ferentiation, necrosis, and neovasculature, which are im-
portant factors reflecting the biological condition of a tu-
mor [2,3]. In the treatment of localized prostate cancer, 
prostate cancer volume may reflect its clinical progression. 
Nevertheless, discordant results have been reported re-
garding whether tumor volume is an independent pre-
dictor for the postoperative prognosis of prostate cancer. 
Although several studies have reported tumor volume to 
be associated with biochemical recurrence following radical 
prostatectomy, this hypothesis is still highly controversial. 
We speculated that the source of this controversy may be 
the diversity of prostate volume among patients. In other 
words, given a constant tumor volume, the rate of positive 
surgical margins in cases with a relatively large prostate 
volume may be lower than in cases with a relatively small 
prostate volume. 
Based on this possibility, we investigated whether the 
ratio of tumor volume to prostate volume was an in-
dependent risk factor for the biochemical recurrence of 
prostate cancer after radical prostatectomy. 
MATERIALS AND METHODS
1. Subjects
This study was conducted on 251 patients who under-
went open retropubic radical prostatectomy for prostate 
cancer in a Severance Hospital from 1998 to 2005. 
Patients who received preoperative hormone therapy or 
whose tumor volume was not measured after the surgery 
were excluded.
2. Methods
Preoperatively, in each patient, prostate volume was 
measured via prostate ultrasonography and PSA levels 
were measured through a blood test. Additionally, in pa-
tients suspected to have prostate cancer based on those re-
sults, prostate cancer was definitively diagnosed via pros-
tate biopsy. The Gleason score was obtained in patients di-
agnosed with prostate cancer. This study included only 
patients definitively diagnosed with prostate cancer who 
underwent radical prostatectomy and whose postopera-
tive tumor volume could be measured using a computer. 
Prostate volume was calculated by converting the weight 
recorded in the pathology report to volume, applying the 
Stanford protocol based on the entire pathological tissue. 
Tumor volume was calculated by summing up the volume 
of all tumors within the prostate using a same method. 
The definition of biochemical recurrence following rad-
ical prostatectomy was at least two instances of PSA levels 
increasing by more than 0.02 ng/mL. We used univariate 
analysis to determine the risk factors associated with bio-
chemical recurrence, including the parameters examined 
preoperatively, tumor volume, and tumor-prostate ratio, 
by assessing their effect on the duration of disease-free 
survival. Multivariate analysis was then performed to ana-
lyze the risk factors that showed a significant relationship 
in the univariate analysis. Additionally, the following post-
operative parameters were included in the analysis: patho-
logical disease stage, PSA level, prostate volume, tumor 
volume, final Gleason score, and the presence of positive 
margins. Tumor-prostate ratio was calculated as the ratio 
of tumor volume to prostate volume, and was in-
corporated into the analysis.
3. Statistical analysis
To evaluate the effect of each factor on biochemical re-
currence following surgery, statistical analysis was per-
formed. Univariate analysis was performed using Kaplan- 
Meier survival analysis. Multivariate analysis was per-
formed using a Cox proportional hazard model. In all stat-
istical analyses were performed using SPSS Statistics ver. 
10.0 (SPSS Inc., Chicago, IL, USA). A p＜0.05 were con-
sidered to indicate statistical significance.
RESULTS
The characteristics of the 251 patients who underwent 
radical prostatectomy were examined. When classified 
based on the volume of the prostate 40 mL; 156 patients 
(62.2%) were found to have had smaller values, while 95 
patients (37.8%) were found to have had larger values. 
When classified based on the PSA 10 ng/mL; 125 patients 
were found to have had higher values, while 126 patients 
were found to have had lower values. Among the patients 
who underwent surgery, 102 patients (40.6%) exhibited 
positive surgical margins (Table 1). In the univariate analy-
sis, the risk factors found to be significantly associated 
with biochemical recurrence were a PSA level ≥10 
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Table 1. Characteristics of the patients who underwent 
radical prostatectomy
Characteristic No. of patient (%)
Age (yr)
 ＜65 115 (45.8)
 ≥65 136 (54.2)
Prostate volume (mL)
 ＜40 156 (62.2)
 ≥40  95 (37.8)
Prostate-specific antigen (ng/mL)
 ＜10 125 (49.8)
 ≥10 126 (50.2)
Gleason score (biopsy)
 ≤6 128 (51.0)
 7  77 (30.7)
 ≥8  46 (18.3)
Clinical stage
 Stage cT1 112 (44.6)
 Stage cT2 105 (41.8)
 Stage cT3  34 (13.5)
Pathologic stage
 Stage pT1   1 (0.4)
 Stage pT2 121 (48.2)
 Stage pT3 101 (40.2)
 Stage pT4  28 (11.2)
Gleason score
 ＜7  89 (35.5)
 ≥7 162 (64.5)
Surgical margin invasion
 No 149 (59.4)
 Yes 102 (40.6)
Capsular invasion
 No 110 (43.8)
 Yes 141 (56.2)
Seminal vesicle invasion
 No 212 (84.5)
 Yes  39 (15.5)
Lymph node invasion
 No 242 (96.4)
 Yes   9 (3.6)
Tumor volume (mL)
 ＜5 208 (82.9)
 ≥5  43 (17.1)
Tumor density
 ＜10 186 (74.1)
 ≥10  65 (25.9)
Pathologic stage pT3c
 ＜pT3c 204 (81.3)
 ≥pT3c  47 (18.7)
Pathologic stage pT4a
 ＜pT4a 223 (88.8)
 ≥pT4a  28 (11.2)
Total 251 (100.0)
Table 2. Univariate analysis of the risk factors for biochemical
recurrence
Risk factor group
5 years of 
recurrence-free 
survival (%)
p-value
Prostate volume (mL) 0.305
 ＜40 71.5
 ≥40 64.4  
Prostate-specific antigen (ng/mL) 0.009
 ＜10 85.3
 ≥10 62.0
Gleason score 0.062
 ＜7 81.1
 ≥7 66.8
Surgical margin invasion 0.000
 No 82.4
 Yes 55.3
Capsular invasion 0.009
 No 76.7
 Yes 68.1  
Seminal vesicle invasion 0.225
 No 72.0
 Yes 65.8  
Lymph node invasion 0.008
 No 72.6
 Yes 38.9
Tumor volume (mL) 0.010
 ＜5 73.4
 ≥5 61.3  
Tumor-prostate ratio (%) 0.007
 ＜10 74.0
 ≥10 62.4
Pathologic stage pT2ca 0.150
 ＜pT2c 59.4
 ≥pT2c 73.9
Pathologic stage pT3aa 0.086
 ＜pT3a 73.5
 ≥pT3a 67.8
Pathologic stage pT3ca 0.032
 ＜pT3c 74.6
 ≥pT3c 60.1
Pathologic stage pT4aa 0.005
 ＜pT4a 74.4
 ≥pT4a 48.0
aClassification according to the standard of American Joint 
Committee on Cancer staging system.
ng/mL (p=0.009), tumor volume ≥5 mL (p＜0.05), cap-
sular invasion (p=0.009), lymph node invasion (p= 
0.008), and positive surgical margins (p=0.000) (Table 2). 
In addition, tumor-prostate ratio ≥10% showed a sig-
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Table 3. Multivariate analysis of the risk factors for biochemical recurrence
p-value HR 95% CI for HR
Surgical margin invasion 0.000 3.066 1.636∼5.745
Tumor-prostate ratio ≥10% 0.026 1.991 1.087∼3.645
HR: hazard ratio, CI: confidence interval.
Fig. 1. Biochemical recurrence-free survival according to tumor 
density, using a cutoff of 10% (p=0.007).
nificant effect on biochemical recurrence (p=0.007) (Fig. 
1).
In the multivariate analysis performed on the risk factors 
established to be significant within the univariate analysis, 
positive surgical margins (hazard ratio [HR]=3.066, p= 
0.000) and tumor-prostate ratio ≥10% were shown to be 
significant risk factors for biochemical recurrence (HR= 
1.991, p=0.026) (Table 3).
DISCUSSION
Radical prostatectomy is still the most important treat-
ment of prostate cancer. Complete resection of the pros-
tate allows prostate cancer to be almost completely cured, 
and numerous urologists employ this treatment modality. 
However, complete resection cannot always be accom-
plished. Due to various factors, such as differences in sur-
gical experience, the effect of previous hormone therapy, 
and efforts to reduce the injury to the neurovascular bun-
dles in order to improve the quality of life of the patient af-
ter surgery, invasion of the surgical margins is occasion-
ally detected in the postoperative pathological findings. 
Therefore, efforts have been made to determine the opti-
mal resection method based on the preoperative con-
dition of the patient and predictions regarding post-
operative progression. With this goal in mind, pre-
operative prognostic factors have been identified. In addi-
tion, postoperative prognostic factors determining wheth-
er additional hormone therapy or radiation therapy is re-
quired also play an important role. 
Positive surgical margins have been confirmed as an im-
portant postoperative prognostic factor [4]. Due to the 
careful selection of patients for surgery and improvements 
in surgical techniques, the incidence of positive surgical 
margins has dramatically decreased over the past 20 years. 
Presently, open abdominal surgery methods, such as the 
suprapubic approach and the perineal approach, do not 
show significantly different outcomes from laparoscopic 
techniques [5-7]. That is, the incidence of positive surgical 
margins due to the surgical method used or differences in 
individual technique can be overcome by ensuring ad-
equate familiarity with the surgical methods. In addition, 
biochemical recurrence, which is strongly associated with 
surgical outcome, may not be very different from each sur-
gical methods. However, tumor volume has also been 
suggested to have a predictive effect in patients clinically 
diagnosed with localized prostate cancer who undergo 
radical prostatectomy, as it may affect the incidence of 
positive surgical margins. Nevertheless, the use of tumor 
volume as a prognostic factor remains controversial. In an 
analysis of the pathological reports of 200 specimens of 
radical prostatectomy, McNeal [8] found that tumor vol-
ume was strongly associated with the Gleason score, the 
pathological disease stage, surgical margin invasion, and 
seminal vesicle invasion. Subsequently, Stamey et al [1] 
reported a mutual association of tumor volume with can-
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Fig. 2. A schematic illustrating a hypothetical scenario in which 
one patient has a larger prostate than the other, with identical 
tumor volumes. The patient with the smaller prostate will likely 
have a worse prognosis.
cer progression. Nelson et al [9] reported that tumor vol-
ume was a significant independent predictive factor. 
However, several studies have reported different results. 
Noguchi et al [10] reported that PSA levels were not a sig-
nificant factor predicting biochemical recurrence after 
radical prostatectomy in men with large volume cancer. 
Marks et al [11] reported that univariate analysis showed 
tumor volume to be a risk factor for biochemical re-
currence, but in multivariate analysis, only PSA levels, dis-
ease stage, and the Gleason score were found to be 
significant. In addition, several studies have argued that al-
though tumor volume may have some value as a prog-
nostic factor, it is less useful than other parameters be-
cause it is cumbersome to calculate. It has been suggested 
that methods measuring the maximal tumor diameter 
should be introduced in order to address this issue, and 
that the ratio of high-grade tumors should be incorporated 
[12-14]. As such, although it is intuitive that the tumor vol-
ume during surgery may have an effect, no consensus ex-
ists in the literature. This may be due to two issues. The first 
has to do with differences in the methods used to measure 
tumor volume. Prostate tumors are rarely present in only 
one area within the prostate; instead, they show an irregu-
lar and scattered pattern. Hence, it is not easy to calculate 
the tumor volume. The method that classifies pathological 
specimens into groups of 1%, 5%, 10%, or 20% based on 
microscopy incorporates many variables, such as the 
number of specimen blocks and the number of specimens 
containing signs of prostate cancer [15]. This procedure 
may fail to detect small tumors [16]. Another method is to 
calculate the tumor volume using computerized analysis. 
Although this is a more accurate method, it is not always 
performed [17-19]. In our study, a computerized volume 
summation analysis method was used to calculate tumor 
volume. Nonetheless, the prognostic value of tumor vol-
ume remains unclear. It may be the case that prostate vol-
ume affects the likelihood of positive surgical margins as 
well. In other words, in two patients with the same tumor 
volume but with different prostate volumes, the likelihood 
of the tumor cells reaching the surgical margins would be 
higher in the patient with the smaller prostate volume (Fig. 2).
In our results, tumor volume appeared to have a sig-
nificant effect in the univariate analysis, but this was not 
confirmed in the multivariate analysis. Instead, tumor- 
prostate ratio and positive surgical margins were shown to 
be independent significant risk factors. Additional studies 
are required to adequately understand the additional sig-
nificance of tumor-prostate ratio as a parameter. In addi-
tion, we obtained interesting results regarding lymph 
node invasion and seminal vesicle invasion. Although 
lymph node invasion was found to be a significant factor 
for biochemical recurrence in the univariate analysis, it 
was not found to be significant in the multivariate analysis. 
It has been generally shown that lymph node invasion typ-
ically takes place in fewer than 1% of cases with a PSA lev-
el ＜10 ng/mL. In our study, lymph node invasion was ob-
served in 0.4% of cases with a PSA level ＜10 ng/mL, in 
contrast to in 3.2% of cases with a PSA level ≥10 ng/mL. 
Lymph node invasion occurred in 3.6% of cases with a 
Gleason score ≥7. Lymph node invasion was not de-
tected in any cases with a Gleason score ＜7. Such results 
are consistent with those of previous studies arguing that it 
is not always necessary to send out frozen nodes for intra-
operative analysis in cases with a PSA level ＜10 ng/mL 
and a Gleason score ＜7 [20].
Few studies have evaluated the prognostic value of 
seminal vesicle invasion. Epstein et al [21] and Ohori et al 
[22] reported that seminal vesicle invasion was not sig-
nificantly associated with the prognosis. Potter et al [23] 
reported that seminal vesicle invasion can be pathologi-
cally classified into several types, with potentially different 
prognoses. Similarly, in our study, no association of semi-
nal vesicle invasion with biochemical recurrence was 
observed. Additional studies on seminal vesicle invasion 
may be required.
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CONCLUSIONS
In cases of localized or locally advanced prostate can-
cer, tumor-prostate ratio was found to be an independent 
risk factor for biochemical recurrence following prostatec-
tomy, along with positive surgical margins. This may ex-
plain the previous contradictory results regarding tumor 
volume.
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